'Heparin' diaporamas de présentation

1.06k views • 92 slides

BLOOD FORMING AGENTS

BLOOD FORMING AGENTS. Clinical Thrombosis. > 2.5 million cases of deep venous thrombosis (DVT) annually > 600.000 cases of pulmonary embolism (PE) per year > 50.000 deaths per year from PE > 11.000 post surgical PE deaths per year. Anti Platelet Drugs. INHIBITORS OF PLATELET AGGREGATION.

856 views • 65 slides

Ramon C. Mora M.D.

Ramon C. Mora M.D. Year Graduated : 1985 School : FEU-NRMF Institute of Medicine Residency : Veterans Memorial Medical Center (1987-1990) Fellowship : National Kidney & Transplant Institute (1990-1992) Affiliations: VMMC, FEU-NRMF MC, UDMC, NKTI. Measures to Optimize

778 views • 51 slides

Anticoagulant therapy

Anticoagulant therapy. Background Cost Benefit Complication. External(F7)15s Internal(F12)1 to6minute Result> prothrombin activator prothrombin (F2)>thrombin>fibrinogen(F1)>fibrin. Clot formation: fibers+platlet+red cell+plasma

654 views • 40 slides

Heparin-Induced Thrombocytopenia

Heparin-Induced Thrombocytopenia. Heparin-- Required for inhibition of thrombin. Thrombin. Heparin ( > 18 monosaccharide units). Antithrombin. Petitou and van Boeckel, Angew Chem Int Ed 2004; 43: 3118. Mechanism of Action of UFH, Fondaparinux, LMWH. Heparin and Clotting.

1.42k views • 36 slides

Anticoagulation

Anticoagulation. Presented by KENNY ALEXANDER, PharmD SLMV Pharmacy Clinical Coordinator. Objectives. Review the pharmacology, indications, dosing, adverse effect profiles of heparin, low molecular weight heparins, Coumadin

988 views • 35 slides

Pharmacology 301.6 Module 6

Pharmacology 301.6 Module 6. DRUGS & BLOOD Anticoagulants, anti-platelet & fibrinolytics Treatment of anemia. Causes of death in Canada 1997: 661 deaths/100,000. http://www.statcan.ca/english/Pgdb/health30b.htm. stroke. liver. cancer. injuries. lung. other. heart disease.

499 views • 35 slides

Parenteral Anticoagulant

Parenteral Anticoagulant. BY : Maha khalid Supervisor : Pro Dr Seham Hafez. Parenteral Anticoagulant. UFH & LMWH all consist of high MW molecules that Are highly ionized (they don't absorbed from GIT they must given by IV infusion or deep SC injection. ( never IM ). LMWH.

1.01k views • 34 slides

Heparin-Induced Thrombocytopenia

Heparin-Induced Thrombocytopenia. DR VINOD G V. HIT. An immunoglobulin-mediated adverse drug reaction characterized by: platelet activation thrombocytopenia thrombotic complications. Incidence. Depends on clinical setting Medical or surgical Type of Heparin UFH-more

513 views • 31 slides

t-PA 4 PE in ED

t-PA 4 PE in ED. Adrian Skinner ED registrar Auckland Hospital 28/11/02. Introduction. Case report Recent literature review Discussion of indications for thrombolysis in PE. Case Report Mr N.H. Presenting complaint 14/09/02 Increasing S.O.B. 3-4 days Chest Pains Several days.

442 views • 30 slides

Heparin

Heparin. Benedict R. Lucchesi, M.D., Ph.D. Department of Pharmacology University of Michigan Medical School. Heparin. Chemistry Low molecular weight fractions of heparin have a high affinity for ACTIVATED FACTOR X (Xa), but have less of an effect on thrombin. I. I. I. I. I. I. I. V.

3.26k views • 27 slides

Drug-Induced Bleeding

Drug-Induced Bleeding. Christian von Heymann. Outline. Pharmacology of unfractionated heparin (UFH) low molecular weight heparin (LMWH) danaparoid hirudin fondaparinux Algorithm for treatment of bleeding induced by these drugs. Unfractionated Heparin (UFH) Pharmacology.

666 views • 26 slides

Commonly Used Medications

724 views • 25 slides

532 views • 24 slides

Spotlight Case December 2006

Spotlight Case December 2006. Hidden Heparins: HIT Happens. Source and Credits. This presentation is based on the December 2006 AHRQ WebM&M Spotlight Case See the full article at http://webmm.ahrq.gov CME credit is available through the Web site

356 views • 24 slides

iBSc: Question 9

393 views • 23 slides

NUR 241: Exit skill

NUR 241: Exit skill. Exit skill for Heparin Administration. Nursing simulation lab contract. For this skill, you will be given a Nursing Simulation Lab Contract, which you will have to sign Students will be required to:

372 views • 22 slides

2003-2004 Review of Anticoagulants, Thrombolytics and Anti-platelet Drugs

2003-2004 Review of Anticoagulants, Thrombolytics and Anti-platelet Drugs. 8 October 2014 11:29 PM. Abciximab. Antiplatelet Anti-GPIIb/IIIa receptor antibody. Anistreplase. Thrombolytic Streptokinase + plasminogen. Argatroban. Anticoagulant Direct thrombin inhibitor.

414 views • 22 slides

Hematologic Aspects of Cardiac Surgery ??????? R3 ? ? ?

Hematologic Aspects of Cardiac Surgery ??????? R3 ? ? ?. Introduction(1) ????????? hematologic management - complex balance between extreme degrees of anticoagulation & restoration of normal hemostasis after the procedure

343 views • 17 slides

REDUCE THE LIKELIHOOD OF PATIENT HARM ASSOCIATED WITH THE USE OF ANTICOAGULANT THERAPY

Module 3. REDUCE THE LIKELIHOOD OF PATIENT HARM ASSOCIATED WITH THE USE OF ANTICOAGULANT THERAPY. ONLY oral unit-dose warfarin, prefilled Fragmin syringes, and premixed heparin drips are used at CHSB. Use Approved Protocols. CHSB Inpatient Anticoagulation Protocol

401 views • 12 slides